Welcome to our dedicated page for Palatin Tech SEC filings (Ticker: PTN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Palatin Technologies, Inc. (PTN) SEC filings page on Stock Titan provides direct access to the company’s official regulatory disclosures, along with AI-assisted context to help interpret them. As a biopharmaceutical issuer focused on melanocortin receptor–based therapeutics, Palatin uses filings such as Form 8-K, proxy statements, and registration statements to report material events, governance matters, and financing activities.
Investors can review Form 8-K reports detailing key corporate developments, including NYSE American delisting notices and appeals, the transition of trading to OTC markets, the implementation of a 1-for-50 reverse stock split, and the subsequent resumption of trading on NYSE American under the PTN symbol. Other 8-K filings describe material agreements, such as the Research Collaboration, License and Patent Assignment Agreement with Boehringer Ingelheim for melanocortin receptor–targeted peptides in retinal diseases, outlining upfront payments, research milestones, and potential development and commercial milestones.
Palatin’s DEF 14A proxy statement and related filings provide information on annual meeting items, including director elections, amendments to the restated certificate of incorporation to effect a reverse stock split, ratification of the independent registered public accounting firm, approvals of warrant-related share issuances, and amendments to the company’s equity incentive plan. These documents also cover advisory votes on executive compensation and the frequency of future say-on-pay votes.
Through this page, users can also locate registration statements referenced in Palatin’s press releases for public offerings, which describe the terms of common stock and warrant issuances used to fund development of its obesity and other programs. Stock Titan’s interface surfaces these filings as they are posted to EDGAR and applies AI-powered summaries to highlight the sections most relevant to PTN—such as capital structure changes, collaboration economics, and listing status updates—so readers can more quickly understand the implications of each document without reading every page in full.